146 related articles for article (PubMed ID: 22588246)
1. Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.
Kondo Y; Ueno Y; Ninomiya M; Tamai K; Tanaka Y; Inoue J; Kakazu E; Kobayashi K; Kimura O; Miura M; Yamamoto T; Kobayashi T; Igarashi T; Shimosegawa T
J Gastroenterol; 2012 Dec; 47(12):1323-35. PubMed ID: 22588246
[TBL] [Abstract][Full Text] [Related]
2. Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.
Miller TR; Weiss JJ; Bräu N; Dieterich DT; Stivala A; Rivera-Mindt M
J Neurovirol; 2017 Apr; 23(2):260-272. PubMed ID: 27896573
[TBL] [Abstract][Full Text] [Related]
3. Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.
Yeh ML; Hsieh MY; Huang CI; Huang CF; Hsieh MH; Liang PC; Lin YH; Hou NJ; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2015 Oct; 94(42):e1837. PubMed ID: 26496327
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment.
Elefsiniotis IS; Vezali E; Kamposioras K; Pantazis KD; Tontorova R; Ketikoglou I; Moulakakis A; Saroglou G
World J Gastroenterol; 2006 Jul; 12(27):4420-4. PubMed ID: 16865790
[TBL] [Abstract][Full Text] [Related]
5. Differences in hepatitis C virus (HCV)-specific CD8 T-cell phenotype during pegylated alpha interferon and ribavirin treatment are related to response to antiviral therapy in patients chronically infected with HCV.
Caetano J; Martinho A; Paiva A; Pais B; Valente C; Luxo C
J Virol; 2008 Aug; 82(15):7567-77. PubMed ID: 18480446
[TBL] [Abstract][Full Text] [Related]
6. Identification of the association of CD28
Han W; Li J; Zhou H; Qian J; Tong Z; Wang W; Zhong J; Xue T; Chen Q; Yao Y; Shao S
J Med Virol; 2020 Dec; 92(12):3534-3544. PubMed ID: 32568409
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review.
Hoan NX; Tong HV; Song LH; Meyer CG; Velavan TP
World J Gastroenterol; 2018 Jan; 24(4):445-460. PubMed ID: 29398866
[TBL] [Abstract][Full Text] [Related]
8. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV.
Campos LB; de Almeida NAA; de Santana CG; Barbosa ENP; Horta MAP; Amendola Pires M; Brandão Mello CE; de Paula VS; de Barros JJF
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680226
[TBL] [Abstract][Full Text] [Related]
9. HCV genotype-3a T cell immunity: specificity, function and impact of therapy.
Humphreys IS; von Delft A; Brown A; Hibbert L; Collier JD; Foster GR; Rahman M; Christian A; Klenerman P; Barnes E
Gut; 2012 Nov; 61(11):1589-99. PubMed ID: 22337948
[TBL] [Abstract][Full Text] [Related]
10. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.
Edlich B; Ahlenstiel G; Zabaleta Azpiroz A; Stoltzfus J; Noureddin M; Serti E; Feld JJ; Liang TJ; Rotman Y; Rehermann B
Hepatology; 2012 Jan; 55(1):39-48. PubMed ID: 21898483
[TBL] [Abstract][Full Text] [Related]
11. Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.
Nyström J; Stenkvist J; Häggblom A; Weiland O; Nowak P
PLoS One; 2015; 10(3):e0118643. PubMed ID: 25785448
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus and Hepatitis B Virus Co-Infection.
Shih YF; Liu CJ
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198
[TBL] [Abstract][Full Text] [Related]
13. Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India.
Gupta V; Kumar A; Sharma P; Arora A
Indian J Med Res; 2017 Jul; 146(1):23-33. PubMed ID: 29168457
[TBL] [Abstract][Full Text] [Related]
14. Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.
Rehermann B; Bertoletti A
Hepatology; 2015 Feb; 61(2):712-21. PubMed ID: 25048716
[TBL] [Abstract][Full Text] [Related]
15. High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.
Gonzalez VD; Falconer K; Blom KG; Reichard O; Mørn B; Laursen AL; Weis N; Alaeus A; Sandberg JK
J Virol; 2009 Nov; 83(21):11407-11. PubMed ID: 19710147
[TBL] [Abstract][Full Text] [Related]
16. NKp30
Shen X; Fu B; Liu Y; Guo C; Ye Y; Sun R; Li J; Tian Z; Wei H
Sci Rep; 2016 Dec; 6():38778. PubMed ID: 27941937
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives.
Maqsood Q; Sumrin A; Iqbal M; Younas S; Hussain N; Mahnoor M; Wajid A
Antivir Ther; 2023 Aug; 28(4):13596535231189643. PubMed ID: 37489502
[TBL] [Abstract][Full Text] [Related]
18. Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective.
Tran HA; Jones TL; Ianna EA; Foy A; Reeves GE
Endocr Pract; 2013; 19(2):292-300. PubMed ID: 23186968
[TBL] [Abstract][Full Text] [Related]
19. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
20. HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients.
Feng G; Zhang JY; Zeng QL; Jin L; Fu J; Yang B; Sun Y; Jiang T; Xu X; Zhang Z; Yuan J; Wu L; Wang FS
Mol Cells; 2013 Oct; 36(4):362-7. PubMed ID: 24170093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
